MICHELLE EDWARDS: Open Payments
NPI 1194039164 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,129 in 30 payments from 12 companies in 2025. Trend: 2023 $460 · 2024 $1,146 · 2025 $1,129
Food & beverage: $1,129
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $325 |
| Novo Nordisk Inc | 4 | $267 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Corcept Therapeutics | 2 | $109 |
| Vanda Pharmaceuticals Inc. | 1 | $100 |
| Amgen Inc. | 3 | $54 |
| ABBVIE INC. | 2 | $39 |
| ViiV Healthcare Company | 1 | $32 |
| Abbott Laboratories | 1 | $29 |
| Dynavax Technologies Corporation | 2 | $19 |
Products named: XIFAXAN, Wegovy, BREZTRI, Korlym, FANAPT, OTEZLA, APRETUDE, ETERNA.
Industry payments across NC — which companies pay providers there.
